These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16610049)
1. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer. Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049 [TBL] [Abstract][Full Text] [Related]
2. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225 [TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology. Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation. Morichetti D; Mazzucchelli R; Santinelli A; Stramazzotti D; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R Int J Immunopathol Pharmacol; 2010; 23(2):511-22. PubMed ID: 20646346 [TBL] [Abstract][Full Text] [Related]
6. Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors. Nakayama Y; Wada R; Yajima N; Hakamada K; Yagihashi S Pancreas; 2010 Nov; 39(8):1147-54. PubMed ID: 20717067 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptors and disease: role of receptor subtypes. Hofland LJ; Lamberts SW Baillieres Clin Endocrinol Metab; 1996 Jan; 10(1):163-76. PubMed ID: 8734455 [TBL] [Abstract][Full Text] [Related]
8. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma. Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322 [TBL] [Abstract][Full Text] [Related]
9. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor subtype gene expression in pituitary adenomas. Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
12. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR. Wang F; Wang Z; Wu J; Qu W; Yao W; Zhao J; Liu Z Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival. Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889 [TBL] [Abstract][Full Text] [Related]
14. Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study. Rufini V; Lorusso M; Inzani F; Pasciuto T; Triumbari EKA; Grillo LR; Locco F; Margaritora S; Pescarmona E; Rindi G Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4182-4193. PubMed ID: 35674739 [TBL] [Abstract][Full Text] [Related]
15. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268 [TBL] [Abstract][Full Text] [Related]
16. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma. Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer. Guo RS; Shi PD; Zhou J; Chen YY Asian Pac J Cancer Prev; 2013; 14(7):4071-5. PubMed ID: 23991955 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. Xie YM; Yan LN; Wei B; Guo MM; Tang CW Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741 [TBL] [Abstract][Full Text] [Related]
19. Selective Interactions of Mouse Melanocortin Receptor Accessory Proteins with Somatostatin Receptors. Wang M; Xu J; Lei XW; Zhang C; Liu SY; Jin LN; Zhang C Cells; 2022 Jan; 11(2):. PubMed ID: 35053382 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin and its receptor family. Patel YC Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]